Permeon Biologics is a developer of therapeutic drugs for the enhancement of human health.
Permeon Biologics aims to enhance human health by using their novel Intraphilin Technology Platform™ to enable intracellular biologics as a revolutionary new generation of therapeutic drugs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 30, 2011 | Series Unknown | $2.50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ARCH Venture Partners | — | Series Unknown |